Treatment of Phantom Limb Pain with Botulinum Toxin Type A: Table 1
- 1 March 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 10 (2), 300-303
- https://doi.org/10.1111/j.1526-4637.2008.00554.x
Abstract
Phantom limb pain and sensations are common in amputees. The pathophysiology remains unclear and the treatment difficult and often unsuccessful. Opioids are frequently used when non-narcotics have failed, but are not effective in many cases. We report on three phantom and stump pain patients, refractive to previous treatments, who were successfully treated with botulinum toxin A (BoNT-A). Three patients who had previously undergone amputation of their leg due to accident (N = 2) or injury by a landmine (N = 1) were treated with BoNT-A (Dysport). We injected a total dose of up to 500 units (U) BoNT-A under EMG-control. Global clinical improvement was based on a 0-3 scale (0 = no effect; 3 = marked improvement) and on a questionnaire rating pain intensity (based on the visual analog scale), intake of pain medication and phantom limb sensations. All three patients evaluated the clinical global improvement with 3 (marked improvement). The pain intensity and pain medication was reduced significantly in all three cases. No side effects were reported. The duration of response lasted up to 11 weeks. These three successfully treated phantom and stump pain patients show that therapy with BoNT-A may be worth studying as an effective and safe treatment option for this kind of pain.Keywords
This publication has 37 references indexed in Scilit:
- Botulinum toxin in clinical practiceJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Effects of Botulinum Toxin Type B on Stump Pain and Involuntary Movements of the StumpAmerican Journal of Physical Medicine & Rehabilitation, 2004
- Myofascial Pain DisordersDrugs, 2004
- Phantom Limb Pain—A Complication of Lower Extremity Wound ManagementThe International Journal of Lower Extremity Wounds, 2002
- The effects of long-standing limb loss on anatomical reorganization of the somatosensory afferents in the brainstem and spinal cordSomatosensory & Motor Research, 2002
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label studyOtolaryngology -- Head and Neck Surgery, 2000
- The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral inputPain, 1996
- Botulinum toxin A for spasticity, muscle spasms, and rigidityNeurology, 1995
- Calcitonin in phantom limb pain: a double-blind studyPain, 1992
- Chronic phantom and stump pain among american veterans: results of a surveyPain, 1984